DILANTIN
- Product NDC
- 58151-110
- 11-digit product format
- 581510110
- Labeler code
- 58151
- Product ID
- 58151-110_872f23a8-e6a3-4038-922d-0c26fc81d8b3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Extended Phenytoin Sodium
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Viatris Specialty LLC
- Application
- ANDA084349
- Marketing category
- ANDA
- Marketing start
- 2024-12-06
- Substance
- PHENYTOIN SODIUM
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A084349-001 | DILANTIN | PHENYTOIN SODIUM | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | ||
| A084349-002 | DILANTIN | PHENYTOIN SODIUM | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A084349-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RS, Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RS, Approved before 1982 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A084349-001 | DILANTIN | 30MG EXTENDED | CAPSULE / ORAL | RLD, RS, Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A084349-002 | DILANTIN | 100MG EXTENDED | CAPSULE / ORAL | AB | RLD, RS, Approved before 1982 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A084349-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A084349-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A084349-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A084349-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A084349-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A084349-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A084349-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A084349-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A084349-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A084349-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A084349-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A084349-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A084349-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A084349-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A084349-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A084349-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A084349-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A084349-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A084349-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A084349-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A084349-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A084349-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A084349-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A084349-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A084349-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A084349-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A084349-002 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A084349-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A084349-002 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A084349-002 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A084349-002 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A084349-002 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A084349-002 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A084349-002 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A084349-002 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A084349-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A084349-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A084349-002 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A084349-002 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A084349-002 | AB | 1 | cb3db0bc1861… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DILANTIN
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PHENYTOIN SODIUM | 100 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4182431BJH | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| be8c0c29-be12-4cae-8e3b-1c71ed6b952c | Product name | 2 | 20250626 |
| e3d31abf-5149-4e77-89a8-0dc73ec106f9 | Product name | 1 | 20210525 |
| b251e19b-cfda-4a5c-8c9c-f4dad5d55ecb | Product name | 2 | 20200303 |
| 031bbc61-0564-1f35-2716-aa5c1d139248 | Product name | 2 | 20141218 |
| cc830ceb-037c-a5c3-ee14-3d82c0e89e70 | Product name | 1 | 20140508 |
| eafc3fd3-6834-3129-5bbb-8a9a495691ab | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58151-110-01 | DILANTIN | 100 in 1 BOTTLE, PLASTIC | CAPSULE, EXTENDED RELEASE | 100 | 3 | |
| 58151-110-10 | DILANTIN | 1000 in 1 BOTTLE, PLASTIC | CAPSULE, EXTENDED RELEASE | 1000 | 3 | |
| 58151-110-32 | DILANTIN | 1 in 1 BLISTER PACK | CAPSULE, EXTENDED RELEASE | 1 | 3 | |
| 58151-110-88 | DILANTIN | 100 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 100 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58151-110-01 | EA - Each | 58151-110 | e83a5537-58db-4591-af60-6df4cece3509 | 1 | 2025-01-14 |
| 58151-110-10 | EA - Each | 58151-110 | dcf7325e-b6cd-441e-b235-24b96615a893 | 1 | 2025-05-14 |
| 58151-110-32 | EA - Each | 58151-110 | 553a82f4-1b61-4d8a-ba26-1a84888dc41d | 1 | 2025-01-14 |
| 58151-110-88 | EA - Each | 58151-110 | 4ecdc811-e103-4e49-ab73-2a6be323f8a4 | 1 | 2025-01-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DILANTIN | EXTENDED PHENYTOIN SODIUM | REMEDYREPACK INC. | db8c69b0-4697-433e-98c7-b0b2d2c52a83 | 2025-10-02 | Warnings, Adverse reactions | 084349 ANDA084349 |
| DILANTIN | EXTENDED PHENYTOIN SODIUM | Viatris Specialty LLC | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 2023-08-21 | Warnings, Adverse reactions | 084349 ANDA084349 58151-110 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 855673 | Dilantin 100 MG Extended Release Oral Capsule | PSN | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855871 | Dilantin 30 MG Extended Release Oral Capsule | PSN | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855671 | phenytoin sodium 100 MG Extended Release Oral Capsule | PSN | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855869 | phenytoin sodium 30 MG Extended Release Oral Capsule | PSN | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855673 | phenytoin sodium 100 MG Extended Release Oral Capsule [Dilantin] | SBD | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855871 | phenytoin sodium 30 MG Extended Release Oral Capsule [Dilantin] | SBD | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855671 | phenytoin sodium 100 MG Extended Release Oral Capsule | SCD | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855869 | phenytoin sodium 30 MG Extended Release Oral Capsule | SCD | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855673 | Dilantin 100 MG Extended Release Oral Capsule | SY | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855871 | Dilantin 30 MG Extended Release Oral Capsule | SY | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855671 | DPH sodium 100 MG Extended Release Oral Capsule | SY | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855673 | DPH sodium 100 MG Extended Release Oral Capsule [Dilantin] | SY | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855869 | DPH sodium 30 MG Extended Release Oral Capsule | SY | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
| 855871 | DPH sodium 30 MG Extended Release Oral Capsule [Dilantin] | SY | 86dd27d1-9cee-48ae-b55d-e2d2f7dbc593 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 58151-110-01 | 58151011001 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-01) | 2024-12-06 | No | No | Current | |
| 58151-110-10 | 58151011010 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-10) | 2025-04-09 | No | No | Current | |
| 58151-110-32 | 58151011032 | 1 in 1 BLISTER PACK | Historical | ||||
| 58151-110-88 | 58151011088 | 100 BLISTER PACK in 1 CARTON (58151-110-88) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (58151-110-32) | 100 blister pack | 2024-12-06 | No | No | Current |